Christine Cassiano | executive |
David Chang | executive |
Geoffrey Parker | executive |
Zachary Roberts | executive |
Michael Yee | analyst |
Tyler Van Buren | analyst |
Salveen Richter | analyst |
Reni Benjamin | analyst |
Luca Issi | analyst |
Asthika Goonewardene | analyst |
Lut Ming Cheng | analyst |
Samantha Corwin | analyst |
Jack Allen | analyst |
John Newman | analyst |
Kalpit Patel | analyst |
Samantha Semenkow | analyst |
Kelsey Goodwin | analyst |
Laura Prendergast | analyst |
Carolina Ibanez-Ventoso | analyst |
Hello, and welcome to the Allogene Therapeutics First Quarter 2024 Conference Call. [Operator Instructions]. Please be aware that today's conference is being recorded. We ask that you limit yourself to 1 question only.
I would now like to turn the conference over to Christine Cassiano, Chief Corporate Affairs and Brand Strategy Officer.